The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population
Abstract
Background and Aim: Although the prognosis for pancreatic cancer is generally poor, it is well known that the survival rate for resected pancreatic cancer is much higher than that for more conservative treatment. The importance of early detection is emphasized for resection of pancreatic cancer. Measurement of serum carbohydrate antigen (CA) 19‐9 has shown satisfactory sensitivity and predictive value in symptomatic patients, but no available data has been found on healthy asymptomatic subjects. Thus, the authors aimed to determine the clinical usefulness of CA 19‐9 as a screening tool for pancreatic cancer in asymptomatic subjects. Methods: From December 1994 to November 2000, 70 940 asymptomatic persons visiting the Health Promotion Center at the Samsung Medical Center, Seoul, Korea, participated. All subjects underwent abdominal ultrasonography and serum CA 19‐9 measurement. The authors analyzed the sensitivity, specificity, and predictive values of CA 19‐9 for detecting pancreatic cancer. Also, those subjects who had a serum CA 19‐9 level above the cut‐off value were followed up using a serial check of CA 19‐9, computed tomography, or endoscopic retrograde cholangiopancreatography. Results: The number of subjects with a level of CA 19‐9 above the cutoff of 37 U/mL was 1063 (1.5%), including four cases diagnosed with pancreatic cancer. The prevalence of pancreatic cancer over the age of 30 years is 13.66 per 100 000 population in Korea. Therefore, the sensitivity is 100% and the specificity 98.5%. However, the positive predictive value of CA 19‐9 for detecting pancreatic cancer is only 0.9% in the asymptomatic population. Conclusion: Mass screening for pancreatic cancer using CA 19‐9 levels in asymptomatic subjects is ineffective because of a very low positive predictive value, despite its high sensitivity and specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorectal carcinoma antigens detected by hybridoma antibodies
Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell Genetics · doi:10.1007/bf01542654 · Cited by 1,364
Clinical epidemiology: The essentials
Valagussa, P. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90054-2 · Cited by 916
(1990) · PubMed · Cited by 579
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.
Del Villano, B. C., Brennan, S., Brock, P., Bucher, C., Liu, V, McClure, M., Rake, B., Space, S., Westrick, B., Schoemaker, H., et al. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.3.549 · Cited by 506
Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
Atkinson, B., Ernst, C. S., Herlyn, M., Steplewski, Z., Sears, H. F., & Koprowski, H. (1982) · PubMed · Cited by 410
Increasing incidence of primary brain lymphoma in the US
Eby, N. L., Grufferman, S., Flannelly, C. M., Schold, S. C., Vogel, F. S., & Burger, P. C. (1988) · Cancer · doi:10.1002/1097-0142(19881201)62:11 · Cited by 386
Evaluation of a Serologic Marker, CA19-9, in the Diagnosis of Pancreatic Cancer
Pleskow, D. K., Berger, H. J., Gyves, J., Allen, E., McLean, A., & Podolsky, D. K. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-9-704 · Cited by 184
Elevated serum levels of tumor marker CA19-9 in acute cholangitis
Albert, M. B., Steinberg, W. M., & Henry, J. P. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01536670 · Cited by 158
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review
Duffy, M. J. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500304 · Cited by 126
CA 19-9 and pancreatic adenocarcinoma
Safi, F., Beger, H. G., Bittner, R., Büchler, M. W., & Krautzberger, W. (1986) · Cancer · Cited by 103
CA19-9 as a Screening and Diagnostic Tool in Symptomatic Patients: The Japanese Experience
Satake, K., Takeuchi, T., Homma, T., & Ozaki, H. (1994) · Pancreas · doi:10.1097/00006676-199411000-00005 · Cited by 77
New carbohydrate tumor markers
Itzkowitz, S. H., & Kim, Y. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90954-6 · Cited by 53
Voorhess, M. L., Brecher, M. L., Glicksman, A. S., Jones, B., Harris, M., Krischer, J. P., Boyett, J. M., Forman, E. N., & Freeman, A. I. (1986) · Cancer · doi:10.1002/1097-0142(19860401)57:7<1324::aid-cncr2820570712>3.0.co;2-a · Cited by 45
Gowland, M., Warwick, F., Kalantzis, N., & Braganza, J. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90367-6 · Cited by 34
Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.
Fabris, C., Del Favero, G., Basso, D., Piccoli, A., Meggiato, T., Angonese, C., Plebani, M., Leandro, G., Burlina, A., & Naccarato, R. (1988) · PubMed · doi:10.1111/j.1572-0241.1988.tb02413.x · Cited by 19
Cited by
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,908
Goonetilleke, K. S., & Siriwardena, A. K. (2007) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2006.10.004 · Cited by 877
Ballehaninna, U. K., & Chamberlain, R. S. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2011.021 · Cited by 701
Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M. T., Allen, P. J., Schattner, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 582
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 489
Metadata
- Authors
- KIM, J., LEE, K. T., LEE, J. K., PAIK, S. W., RHEE, J. C., & CHOI, K. W.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2004-01-05
- Volume
- 19
- Issue
- 2
- Pages
- 182-186
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W1982821807
- Cited by
- 394
- References
- 15
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.